Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Our paper of the month is a phase 3, double-blind, multicentre, trial investigating the efficacy and the safety of vorasidenib, a dual inhibitor of the IDH1 and IHD2 enzymes, in patients with residual or recurrent IDH mutant grade 2 gliomas.